A key event for researchers and clinicians in the Greater South-West (GSO), the Annual Meeting is the place to meet and discuss about programs and strategic axes of the Canceropole. This meeting fosters the network between scientific communities and helps build strong collaborations and new projects.
The 20th Annual Meeting of the Canceropole GSO will take place from November 20th to 22nd at the Congress Center of Perpignan
- Discover the work of renowned international keynote speakers and researchers & clinicians from the GSO during the numerous plenary and parallel sessions;
- Oral communications and posters will allow researchers & clinicians from the GSO to present their last results, technological platform offers and industrial partnerships;
- A « Young Scientists » poster competition – only for PhD students, post-docs and residents.
NEW: to limit our ecological footprint, we organize a bus transportation from Bordeaux, Toulouse and Montpellier.
Program
14:00 – 15:45: Parallel sessions organized by Cancéropôle GSO Axes
- Cell signaling, microenvironment and targeting / Axis 1 session
- KEYNOTE SPEAKER Thomas BERTERO, Institute of Molecular and Cellular Pharmacology, Valbonne – Mechano-metabolism: From tissues to molecules
- Océane MARTIN, Institute of Cellular Biochemistry and Genetics (IBGC), Bordeaux – Gut inflammation impacts glioblastoma development and therapeutic resistance
- Myroslava SLIUSAR, BoRdeaux Institute of Oncology (BRIC), Bordeaux – Role of carbohydrate-binding proteins in controlling glioblastoma stem cell fate and tumorigenesis
- Renaud POINCLOUX, Pharmacology and Structural Biology Institute (IPBS), Toulouse – Macrophage mechanobiology: from tumour infiltration to the generation of protrusive forces during migration and phagocytosis
- Grégoire MANAUD, BoRdeaux Institute of Oncology (BRIC), Bordeaux – Deciphering the oncogenic properties of Fascin-1 in Hepatoblastoma
- Precision therapeutics (1) – Health technologies / Axis 5 session
- KEYNOTE SPEAKER Christoph MERTEN, Ecole Polytechnique Federale de Lausanne (Switzerland) – Biomedical microfluidics, new approaches for drug discovery and personalized cancer therapy
- Myriam CHAUMEIL, University of California, San Francisco (USA) – Hyperpolarized 13C metabolic MRI for adaptive cancer treatment and precision medicine
- Chloé BAZILE, Cancer Research Center of Toulouse (CRCT) – TAM Targeting with vectorized magnetic nanoparticles for anticancer therapies
17:15 – 19:00: Parallel sessions organized by Cancéropôle GSO Axes
- Genome Dynamics & Expression / Axis 2 session
- KEYNOTE SPEAKER José Ignacio MARTIN-SUBERO, August Pi Sunyer Biomedical Research Institute (IDIBAPS) & Catalan Institution for Research and Advanced Studies (ICREA), Barcelona (Spain) – An epigenetic journey into the origin and evolution of chronic lymphocytic leukemia
- Marta RADMAN-LIVAJA, Institute of Molecular Genetics of Montpellier (IGMM), Montpellier – In vivo chromatin footprinting with nanopore sequencing reveals a new role for the yeast heterochromatin protein Sir3 in global transcription regulation
- Luana CINTORI, Molecular, Cellular and Developmental biology unit (MCD, CBI), Toulouse – Novel optogenetic tool for targeted oxidative DNA damage generation : effect of ROS on gene transcription
- Léa BOUTON, Nucleic Acids: Natural and Artificial Regulations Laboratory (ARNA), Bordeaux – Development of RNA therapeutics targeting RBM39 as an anti-cancer strategy
- Virginie MIEULET, Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Toulouse – MAPK-mediated translational regulation of QARS contributes to DNA damage response in high-grade serous ovarian cancers
- Precision therapeutics (2) – Therapeutic innovation and biomarkers / Axis 3 session
- KEYNOTE SPEAKERS Isabelle VAN SEUNINGEN, ONCOLille & Nicolas LEBEGUE, Lille Neuroscience & Cognition, Lille – Emerging paradigms and recent progress in targeting ErbB/HER in cancers
- Emmanuelle LIAUDET-COOPMAN, Montpellier Cancer Research Institute (IRCM), Montpellier – Immunotherapy of triple-negative breast cancers with cathepsin D targeting antibodies
- Angela AGAËSSE, Cancer Research Center of Toulouse – Magnetic hyperthermia and magnetic-mechanical ablation, two potential strategies for inducing an anti-tumor immune response in pancreatic ductal adenocarcinoma
- Lisa BRUNET, Montpellier Cancer Research Institute – Exploiting vulnerabilities in MET-driven non-small cell lung cancer
- Lucile BANSARD, Institute of Functional Genomics, Montpellier – A potent agonist-based PROTAC targeting Pregnane X Receptor that delays colon cancer relapse
- Isabel GALEANO-OTERO, BoRdeaux Institute of Oncology – Sulconazole prevents T-cell exhaustion and promotes cancer cell malignant phenotype repression by attenuation of NF-?B and calcium signaling
08:45 – 09:00: Opening ceremony
Nadine HOUEDE, Scientific director of Cancéropôle Grand Sud-Ouest
09:00 – 10:45: Plenary session
- Cancer microenvironment
- KEYNOTE SPEAKER Hervé FRIDMAN, Centre de Recherche des Cordeliers, Paris – Tumor microenvironment and response to immunotherapy
- Rawan HALLAL, Institute of Molecular Genetics of Montpellier – Targeting the SUMO pathway to activate an anti-tumoral response mediated by Natural Killer cells in Acute myeloid leukemia
- Tommy CHASTEL, Montpellier Cancer Research Institute – Role of Eicosanoid Receptor in Stroma – Cancer Communication
- Marine HERNANDEZ, Pharmacology and Structural Biology Institute, Toulouse – A metabolic crosstalk occurs between human bone marrow adipocytes and prostate cancer cells
10:45 – 11:15: Cancer Research in Bordeaux at a glance
Frédéric SALTEL, BoRdeaux Institute of Oncology (Bordeaux)
14:00 – 15:30: Plenary session and session Axe 4
- Alternative models for translational research
Chairs: Julie PANNEQUIN and Pierre CORDELIER- KEYNOTE SPEAKER Fanny JAULIN, Gustave Roussy Institute, Villejuif – Functional personalized medicine in digestive cancers
- Céline GONGORA, Montpellier Cancer Research Institute, Montpellier – An in vitro heterotypic spheroid model to characterize anti-tumor immunity in chemotherapy and immunotherapy-treated urothelial carcinoma
- Kasandra AGUILAR CAZAREZ, Institute for Functional Genomics, Montpellier – Study of the reciprocal interactions between diffuse low-grade glioma IDH1 mutant cells and neurons
- La Méthodologie et réglementation dans la recherche Interventionelle en Santé des Populations (1) (in french) / session Axe 4
- Cyrille DELPIERRE, Centre d’épidémiologie et de recherche en santé des populations, Toulouse – Les méthodologies en recherche interventionnelle en santé des populations / présentation du réseau SORISP
- Florence COUSSON-GELIE, Institut du Cancer de Montpellier – Les méthodologies en recherche interventionnelle en santé des populations / présentation du réseau SORISP
- Mathieu GOURLAN, Institut du Cancer de Montpellier – Le Grand Défi Vivez Bougez
16:30 – 18:00: Plenary session and session Axe 4
- Cellular plasticity
- KEYNOTE SPEAKER Alejo RODRIGUEZ-FRATICELLI, IRB Barcelona, Barcelona Institute of Science and Technology and Catalan Institute for Research and Advanced Studies (ICREA), Barcelona (Spain) – Pre-existing stem cell heterogeneity as a driver of cancer evolution
- Jérôme TORRISANI, Cancer Research Center of Toulouse (CRCT), Toulouse – The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and DNA damage response in pancreatic carcinogenesis
- Anissa ZAAFOUR, BoRdeaux Institute of Oncology (Bordeaux) – Modelling metastatic dormancy of cancer stem cells in gastric cancer
- David BRACQUEMOND, Institut de Recherche en Cancérologie de Montpellier (Montpellier) – Overcoming osimertinib resistance in EGFR-driven lung cancer by targeting drug tolerant persister cells
- La Méthodologie et réglementation dans la recherche Interventionelle en Santé des Populations (2) (in french) / session Axe 4
- Niamh REDMOND, Université Paul Sabatier, Toulouse – Dépistage cancer colorectal zones défavorisées (DECODE)
- Discussion des défis réglementaires dans la recherche interventionnelle en santé des populations avec un expert en éthique
18:00 – 19:00:
09:00 – 10:30: Plenary session and session Axe 4
- Translational research in rare cancers
- KEYNOTE SPEAKER Isabelle JANOUEIX, Institut Curie, Paris – Non-genetic heterogeneity and phenotypic plasticity in neuroblastoma
- KEYNOTE SPEAKER Florent PEYRAUD, Institut Bergonié, Bordeaux – Immunotherapy in Sarcomas : from Bench to Bedside
- L’intégration des patients partenaires en recherche (in french) / session Axe 4
- Patrick LARTIGUET, Université Jean Jaures, Toulouse – La participation des patients dans les projets de recherche
- Célia CARDOSO, Institut Imagine, Paris – Co-construction d’un programme de partenariat patient dans un Institut Hospitalo-Universitaire : inspiration concrète
11:30 – 13:00: Plenary session and session Axe 4
- Metastasis
- KEYNOTE SPEAKER Jacky GOETZ, Tumor Biomechanics Lab, INSERM/Unistra, CRBS (Strasbourg) – Nanoscale tracking of Metastasis
- Inès GARROUCHE, Université de Poitiers, ProDiCeT (Poitiers) – New insights of YAP activity in brain metastases from colorectal cancer
- Tra-Ly NGUYEN, BoRdeaux Institute of Oncology (Bordeaux) – Role of immunosuppressive myeloid cells on gastric cancer stemness promotion
- Julie PANNEQUIN, Institute for Functional Genomics (Montpellier) – Unraveling the metastatic process in colorectal cancer
- Les recherches sur les soins de support (in french) / session Axe 4
- Maria Claudia ADDAMIANO, Université Paul Sabatier, Toulouse – Présentation du projet de recherche ASSOAC
- Kerstin FARAVEL, Institut du Cancer de Montpellier – La prise en charge Kiné-Yoga-ETP
- Véronique GERAT-MULLER, Institut Bergonié, Bordeaux – onCOGITE
Abstract submission
Deadlines
Oral communication : September 13
Poster : September 13 October 7
To submit an abstract, you must first register
Registration
Congress fees include all sessions attendance and access to the online abstracts
Attendance fees | ||||
Young academics (PhD student, post-doc, resident) |
Academics (permanent staff) |
GSO Start-ups* | Industry | |
Registration before Sept. 13rd | 30 € | 50 € | 200 € | 400 € |
Registration after Sept. 13rd | 50 € | 100 € | 300 € | 600 € |
• Attendance to the gala event on Thursday Nov 21st at the Congress Center (dinner and animations) is not included in the congress fees. Gala event supplementary cost :
- Young researchers: 25 €
- Academics: 40 €
- GSO Start-ups: 100 €*
- Industry: 150 €
* Start-ups from the GSO: start-ups from Occitanie and Nouvelle Aquitaine regions, created after 2018 and with no more than 5 employees. If these criteria don’t apply, industrial fees apply.
Payment
Your contact : Pascale MOREAU – +336 03 01 39 22
Your registration is done when congress fees are paid. An email will be sent to you personally.
- If you wish to pay your registration by check, please send your payment to the order of Cancéropôle GSO at the following address :
Cancéropôle Grand Sud-Ouest, 5 Avenue Irène Joliot-Curie – 31100 TOULOUSE
- If you wish to pay your registration by order form (bank transfer), you MUST include on the order form the name and registration number of all persons concerned by this payment. The order form must be in the name of the Cancéropôle GSO and must be sent by email.
- If you have not completed and/or paid your registration, you will be able to do so on site at the welcome desk. PLEASE NOTE : only payments by check will be accepted (an invoice will be sent to you by email the following week).
Votre inscription sera prise en compte et validée dès réception du règlement et vous sera confirmée par email.
- Si vous souhaitez régler votre inscription par chèque, merci d’adresser votre règlement à l’ordre du Cancéropôle GSO à l’adresse suivante :
Cancéropôle Grand Sud-Ouest 5 Avenue Irène Joliot-Curie – 31100 TOULOUSE
- Si vous souhaitez régler votre inscription par bon de commande (virement), merci de faire figurer IMPERATIVEMENT sur le bon de commande le nom et numéro d’inscription des personnes concernées par ce règlement. Merci d’établir votre bon de commande au nom du Cancéropôle GSO et de l’adresser par mail.
- Si toutefois vous n’avez pas effectué et/ou réglé votre inscription, il vous sera possible de le faire sur place à l’accueil. ATTENTION : seuls les règlements par chèques seront acceptés (une facture justificative vous sera adressée par mail la semaine suivante).
Congress venue, bus and accomodation